Sabra Healthcare REIT (NASDAQ:SBRA) Research Coverage Started at Huntington

Huntington started coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a report issued on Thursday morning, MarketBeat reports. The brokerage issued an outperform rating and a $23.00 target price on the real estate investment trust’s stock.

Other research analysts also recently issued research reports about the company. Wells Fargo & Company lifted their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Mizuho set a $21.00 target price on Sabra Healthcare REIT in a report on Monday, August 31st. Robert W. Baird raised their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research report on Monday, August 31st. Weiss Ratings cut Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, August 4th. Finally, Truist Financial lifted their price target on Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Wednesday, July 22nd. Seven research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT has a consensus rating of “Moderate Buy” and an average target price of $22.23.

Sabra Healthcare REIT Price Performance

Shares of Sabra Healthcare REIT stock opened at $20.52 on Thursday. Sabra Healthcare REIT has a 52-week low of $17.17 and a 52-week high of $22.77. The stock has a market capitalization of $5.24 billion, a price-to-earnings ratio of 78.93, a price-to-earnings-growth ratio of 1.56 and a beta of 0.65. The company has a fifty day moving average of $20.70 and a 200-day moving average of $20.21. The company has a debt-to-equity ratio of 0.95, a quick ratio of 3.07 and a current ratio of 3.07.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The business had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a return on equity of 2.34% and a net margin of 7.61%.Sabra Healthcare REIT’s revenue for the quarter was up 24.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.38 EPS. Equities research analysts expect that Sabra Healthcare REIT will post 1.52 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were given a $0.30 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.8%. Sabra Healthcare REIT’s payout ratio is presently 461.54%.

Insider Activity

In other news, CEO Richard Matros sold 200,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. This represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.09% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Core Capital Management & Research inc. bought a new position in Sabra Healthcare REIT during the 2nd quarter valued at approximately $204,000. Tidal Investments LLC grew its position in shares of Sabra Healthcare REIT by 204.1% in the 2nd quarter. Tidal Investments LLC now owns 37,958 shares of the real estate investment trust’s stock worth $741,000 after buying an additional 25,477 shares during the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of Sabra Healthcare REIT in the 2nd quarter worth approximately $61,000. NewEdge Advisors LLC increased its stake in shares of Sabra Healthcare REIT by 261.2% during the second quarter. NewEdge Advisors LLC now owns 71,128 shares of the real estate investment trust’s stock valued at $1,388,000 after buying an additional 51,435 shares during the period. Finally, Baird Financial Group Inc. increased its stake in shares of Sabra Healthcare REIT by 7.3% during the second quarter. Baird Financial Group Inc. now owns 16,632 shares of the real estate investment trust’s stock valued at $324,000 after buying an additional 1,134 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties. The company primarily focuses on skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Sabra generally leases its properties to healthcare operators under long-term agreements, including triple-net leases, and may provide mortgage loans or other forms of financing to healthcare providers. Its portfolio serves healthcare markets across the United States and Canada.

Founded in 2010 and headquartered in Irvine, California, Sabra became a publicly traded company in 2010.